Gyre Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $27,872 | $25,488 | $25,225 | $27,172 |
Gross Profit | 26,695 | 24,530 | 24,455 | 26,193 |
EBITDA | 1,134 | 4,233 | 3,500 | 8,496 |
EBIT | 663 | 3,262 | 8,071 | |
Net Income | 12,474 | 5,004 | 3,528 | 7,532 |
Net Change In Cash | 27,872 | 25,488 | 25,225 | 27,172 |
Free Cash Flow | -2,693 | 1,033 | -6,949 | 2,653 |
Cash | 11,813 | 15,866 | 16,097 | 29,785 |
Basic Shares | 102,293 | 102,640 | 104,325 | 102,594 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $105,757 | $113,450 | $794 | $7,338 |
Gross Profit | 101,873 | 108,814 | -4 | -42 |
EBITDA | 16,163 | 20,327 | 10,332 | -87,604 |
EBIT | 16,229 | 19,213 | 9,203 | -87,894 |
Net Income | 12,085 | -92,933 | 2,302 | -87,933 |
Net Change In Cash | 105,757 | 113,450 | 794 | 7,338 |
Free Cash Flow | -5,956 | 17,306 | -38,094 | -84,594 |
Cash | 11,813 | 33,509 | 21,666 | 44,347 |
Basic Shares | 102,293 | 65,831 | 75,686 | 30,640 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.001 |
2024-09-30 | $0.01 |
2024-06-30 | $0.03 |
2024-03-31 | $0.03 |
